TORRANCE, Calif., Jan. 25, 2021 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTC: EMMA), a leader in the treatment of sickle cell disease, reported today its financial results for the year ended December 31, 2019 and its restated financial results for the year ended December 31, 2018. As previously disclosed in the Current Report on Form 8-K filed
HOUSTON–(BUSINESS WIRE)–Feb 4, 2021– PROS Holdings, Inc. (NYSE: PRO), a provider of AI-powered solutions that…
CLEVELAND–(BUSINESS WIRE)–SIFCO Industries, Inc. (NYSE American: SIF) today announced financial results for its first quarter…
Push release content from Globe Newswire. The AP information employees was not concerned in its…
JERUSALEM, Jan. 28, 2021 /PRNewswire/ — BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused…
GOLETA, Calif., Feb. 4, 2021 /PRNewswire/ — Deckers Brands (NYSE: DECK), a global leader in…
MANISTIQUE, Mich., Jan. 28, 2021 (GLOBE NEWSWIRE) — Mackinac Financial Corporation (Nasdaq: MFNC) (the “Corporation”),…
CAMPBELL, Calif.–(BUSINESS WIRE)–Jan 28, 2021–8×8, Inc. (NYSE: EGHT), a leading integrated cloud communications platform, today…
LYNNWOOD, Wash.–(BUSINESS WIRE)–Jan 28, 2021–U & I Financial Corp. (OTCQX: UNIF), the holding company for…
SPARTA, Mich., Jan. 30, 2021 /PRNewswire/ — ChoiceOne Financial Services, Inc. (“ChoiceOne”, NASDAQ:COFS), the parent…
Achieves Fiscal Year 2020 Net Income Per Diluted Share of $0.05 Compared to a Net…
The MarketWatch News Department was not involved in the creation of this content. NEW YORK,…
NASHVILLE, Tenn.–(BUSINESS WIRE)–Jan 25, 2021–FB Financial Corporation (the “Company”) (NYSE: FBK), parent company of FirstBank,…